Ace Therapeutics, a leading IBD research service company, revealed its novel IBD animal models, created to bridge the complex challenges of IBD drug discovery and innovative therapy development. The news is a significant milestone in bridging the gap between preclinical research and clinical success, as part of global efforts towards advancing precision medicine and regulatory compliance in...